TWA
HRMY icon

TCI Wealth Advisors’s Harmony Biosciences HRMY Stock Holding History

TCI Wealth Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-117
Closed -$3.82K – 1098
2023
Q1 		$3.82K Sell
117
-50
-30% -$2.28K ﹤0.01% 1715
2022
Q4 		$9.2K Buy
167
+50
+43% +$2.75K ﹤0.01% 1130
2022
Q3 		$5K Hold
117
– – ﹤0.01% 1461
2022
Q2 		$6K Buy
117
+35
+43% +$1.58K ﹤0.01% 1352
2022
Q1 		$4K Hold
82
– – ﹤0.01% 1712
2021
Q4 		$3K Hold
82
– – ﹤0.01% 2003
2021
Q3 		$3K Hold
82
– – ﹤0.01% 1937
2021
Q2 		$2K Buy
+82
New +$2.46K ﹤0.01% 2018

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TCI Wealth Advisors's HRMY Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Harmony Biosciences (HRMY) in Q2 2023, closing a stake of 117 shares — an estimated $3.82K sold.

TCI Wealth Advisors first reported a position in HRMY in Q2 2021 and held it in 8 quarters. The position peaked at $9.2K in Q4 2022. 211 funds tracked by Wall St. Rank hold HRMY as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Harmony Biosciences position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 117 Harmony Biosciences shares in Q2 2023, an estimated $3.82K.
  • TCI Wealth Advisors first reported a position in Harmony Biosciences in Q2 2021 and held it in 8 quarters.
  • TCI Wealth Advisors's Harmony Biosciences position peaked at $9.2K in Q4 2022.
  • 211 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.